Back to search
FDAFDA · Food and drugs·Recall number Z-1903-2012

PTS Panels Creatinine test strips. PTS Panels Creatinine Test Strips are intended to measure creatinine in whole blood. Creatinine measurements are used in the diagnosis and treatment of renal (kidney) diseases and in the monitoring of renal dialysis. This system is intended for the professional use for accurately and reproducibly measuring creatinine in human whole blood obtained from a finger stick sample

Published July 4, 2012 · Recall initiated: May 15, 2012

Summary

FDA records medical device Class II recall Z-1903-2012, published July 4, 2012 and initiated May 15, 2012. Recalling firm: Polymer Technology Systems, Inc.; Status: Terminated; Reported quantity: 1650 vials; Lot: Cat No. 1720; and Lot number F103. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

During a routine product investigation, a creatinine sample with a value less than 1.0 mg/dl was tested on a version 2.60 CardioCek PA meter and the meter provided a result of 0.08mg/dl, which is not the reportable measuring range for the CardioChek PA meter for the creatinine assay.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Polymer Technology Systems, Inc.
Distributor
Worldwide Distribution -- Nationwide Distribution including the states of CA and VA., and the countries of China, Poland, Ireland and France.
Lot
Cat No. 1720; and Lot number F103
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was PTS Panels Creatinine test strips. PTS Panels Creatinine Test Strips are intended to measure creatinine in whole blood. Creatinine measurements are used in the diagnosis and treatment of renal (kidney) diseases and in the monitoring of renal dialysis. This system is intended for the professional use for accurately and reproducibly measuring creatinine in human whole blood obtained from a finger stick sample recalled?

Yes. FDA published recall Z-1903-2012 on July 4, 2012. Reported hazard: During a routine product investigation, a creatinine sample with a value less than 1.0 mg/dl was tested on a version 2.60 CardioCek PA meter and the meter provided a result of 0.08mg/dl, which is not the reportable measuring range for the CardioChek PA meter for the creatinine assay.

What should I do if I have this product?

Voluntary: Firm initiated · Letter